Chair(s): Michael Kreuter, Marlies S. Wijsenbeek
Session type: Symposium
Elizabeth Robertson
Session content
Patient's perspective
Elizabeth Robertson
Replay
Phil Molyneaux
Replay
Slides
Anna Podolanczuk
Replay
Slides
Moises Eduardo Selman Lama
Replay
Elisabeth Bendstrup
Replay
Slides
Discussion and Q&A
Session aims
to describe the magnitude of the problem of progressive pulmonary fibrosis (PPF); to discuss the diagnostic tools to detect or predict PPF; to explore some of the putative pathogenic mechanisms that may be involved in the progression of fibrotic lung disorder; to discuss the therapeutic approach, covering immunosuppression and antifibrotic drugs, antifibrotic drugs alone, nonpharmacological support, and when to start and stop this all.